Group 1 - The total box office for the 2025 film market has reached 51.074 billion yuan, significantly surpassing the same period in 2024 [1][2] - The 2025 New Year’s film season has generated a box office of 4.587 billion yuan, exceeding the total box office of the 2024 and 2023 New Year’s film seasons [1][2] - The 2025 New Year’s film season runs for 34 days from November 28 to December 31, while the 2023 and 2024 seasons lasted 38 and 40 days, respectively [1] Group 2 - Upcoming films include the fantasy adventure "The Legend of the Condor Heroes," which is set to release on December 31, with 173,000 people expressing interest [2] - The suspense film "The Hidden Kill" is also scheduled for December 31, with previous works by the director achieving box office success [2] - The animated short film collection "Chinese Folktales 2" will be exclusively released on Bilibili starting January 1, 2026 [3]

Group 1 - The film industry sector is experiencing a volatile rebound, with Beijing Culture hitting the daily limit up [1] - Other companies such as Zhongnan Culture, Bona Film Group, Huazhi Digital Media, Happy Blue Ocean, China Film, and Huace Film & Television are also seeing gains [1]

（文章来源：证券日报） 证券日报网讯 12月22日，幸福蓝海发布公告称，公司第五届董事会第十五次会议审议通过《关于聘任 公司高级管理人员的议案》等。 ...

Group 1 - Rongchang Biotech plans to repurchase shares worth between 20 million and 40 million yuan, with a maximum price of 95 yuan per share, aiming to buy back approximately 21,050 to 42,110 shares, representing about 0.04% to 0.07% of total share capital [1] - Nanya New Materials intends to raise no more than 900 million yuan through a private placement for AI computing power-based high-frequency high-speed copper-clad laminate R&D and working capital [2] - Xiechuang Data has signed a strategic cooperation agreement with Ping An Financial Leasing, aiming for a cooperation scale of 2 billion yuan over three years [3] Group 2 - Chuangshi Technology's controlling shareholder is under investigation and has been placed under detention, having resigned from all positions in the company [4] - Deep Kangjia A has reported overdue shareholder loans to Yikang Technology and Chuzhou Kangxin, totaling approximately 233 million yuan and 395 million yuan respectively, due to repayment issues [5] - Ningbo Yuanyang announced the resignation of two directors due to work adjustments [6] Group 3 - China Merchants Energy has delivered the world's first methanol dual-fuel VLCC oil tanker, with 15 oil tanker orders in hand [7] - Tianyu Co., Ltd. has received a drug registration certificate for hydrochloride trazodone tablets, which are used for treating depression [8] - Haizheng Pharmaceutical has received FDA approval for clinical trials of HS387 tablets for treating advanced solid tumors [9] Group 4 - Warner Pharmaceuticals has obtained a drug registration certificate for isoproterenol hydrochloride injection, used for treating shock and complete atrioventricular block [10] - Hekang New Energy's subsidiary received a government subsidy of 1.5 million yuan, which accounts for 14.57% of the company's latest audited net profit [11] - Duku Culture is planning a change in company control, with stock suspension expected for no more than two trading days [12] Group 5 - Haisco has received acceptance for an IND application for HSK46575 tablets for prostate cancer treatment [13] - *ST Xinyan is executing a capital reserve transfer to increase share capital, resulting in a stock suspension [14] - Nanjing Public Utilities is transferring a 45% stake in a subsidiary for 23.6443 million yuan [15] Group 6 - Action Education plans to repurchase shares worth between 20 million and 25 million yuan, with a maximum price of 45 yuan per share [16] - Bai'ao Tai has received government subsidies totaling 29 million yuan [18] - Weisi Medical intends to sell assets worth 119 million yuan, expecting a profit impact of approximately 10 million yuan [19] Group 7 - Tongyu Communications plans to increase capital by 10 million yuan to introduce investment from Wuchuang Institute [20] - Dongtu Technology's subsidiary is introducing strategic investor Guofeng Investment Fund with a capital increase of 11 million yuan [21] - China General Nuclear Power Technology's shareholder is facing a judicial auction of 2.91% of the company's shares [22] Group 8 - Nanshan Aluminum plans to repurchase shares worth between 300 million and 600 million yuan, with a maximum price of 7.52 yuan per share [23] - Yipin Hong's controlling shareholder has committed to transferring 9.07% equity in Arthrosi without compensation [24] - Sanli Pharmaceutical has signed a technology transfer contract worth 200 million yuan with Hainan University [25] Group 9 - Xin Nuo Wei plans to jointly invest 450 million yuan with Zhongqi Pharmaceutical to establish a joint venture focusing on innovative metabolic drugs [26] - Li Qun Co. has been approved to issue 1 billion yuan in medium-term notes to optimize debt structure and supplement working capital [27] - Dongfang Ocean's subsidiary has received a medical device registration certificate for a procalcitonin test kit [28] Group 10 - Tibet Mining's chairman has resigned due to work adjustments [29] - Wantai Biological's subsidiary has been shortlisted for a national immunization program vaccine procurement project, with a bid price of 27.5 yuan [30] - Xingfu Blue Sea has appointed Zhang Chen as the new deputy general manager [31] Group 11 - Changyuan Donggu has elected Li Yixuan as the vice chairman of the board [32] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Dahuang Robotics for collaboration in humanoid robot development [33] - Yongda Co. has been pre-selected for a procurement project worth approximately 350 million yuan [34] Group 12 - Fuan Pharmaceutical's subsidiary has received a drug registration certificate for hydrochloride trazodone tablets [35] - Nanjing Food reported a 71.03% year-on-year decrease in net profit for November due to rising raw material costs [36] - Changqing Technology's special polymer monomer project has commenced production [37]

关于调整公司组织架构的公告 证券代码：300528 证券简称：幸福蓝海 公告编号：2025-066 幸福蓝海影视文化集团股份有限公司 调整后的公司组织架构图见附图。 特此公告。 幸福蓝海影视文化集团股份有限公司董事会 2025年12月22日 股东会 战略委员会 提名委员会 董事会 薪酬与考核委员会 审计委员会 总经理(经营管理层) 行 法 战 数 内 董 财 务 控 事 务 智 略 政 会 办公 人事 资 广 部 品 科 宙 计 lg 牌 部 部 部 部 部 室 T ] 北 江 江 江 江 江 江 江 京 赤 苏 赤 赤 赤 苏 苏 广告分 主 福 幸福 猫 キ 福 溢 天 幸福 猫 幸 盛 世 版 地 影 纵 海 海 海 海 视 横 海 公 院 影 影 传 文 影 中 司 线 天 개 院 化 视 媒 有 有 有 龙影 发 有 文 限 限 化 限 展 限 投 责 责 责 视 有 公 资 任 限 任 司 文 任 责 公 有 化 公 公 任 限 有 司 司 司 限 公 公 责 司 司 tt 公 司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 为确保公司持续高效 ...

证券代码：300528 证券简称：幸福蓝海 公告编号：2025-065 附相关人员简历： 张晨：男，1985 年 6 月出生，中国国籍，无永久境外居留权，大学本科学 历。2008 年 7 月起至江苏省广播电视集团有限公司工作，2016 年 3 月至 2019 年 2 月任江苏省广播电视集团有限公司地面频道广告营销中心副主任，2019 年 2 月至 2020 年 6 月任江苏省广播电视集团有限公司卫视频道综合管理中心商务开 发部主任，2020 年 6 月起至今任江苏省广播电视集团有限公司卫视频道商务推 广中心副主任。 关于聘任公司高级管理人员的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 幸福蓝海影视文化集团股份有限公司（以下简称"公司"）于 2025 年 12 月 22 日召开的第五届董事会第十五次会议审议通过了《关于聘任公司高级管理人 员的议案》。根据《公司法》等相关法律法规及公司章程的规定，结合公司实际 经营管理需要，经公司副董事长兼总经理张烨镝先生提名及提名委员会审议，公 司董事会同意聘任张晨先生为公司副总经理，任职期限自公司董事会审议通过之 日 ...

证券代码：300528 证券简称：幸福蓝海 公告编号：2025-064 幸福蓝海影视文化集团股份有限公司 第五届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 幸福蓝海影视文化集团股份有限公司（以下简称"公司"）第五届董事会第 十五次会议通知于 2025 年 12 月 10 日以邮件和电话的方式发出。会议于 2025 年 12 月 22 日上午 09:00 在南京市栖霞区元化路 8 号 28 幢（仙林南大科学园智 慧园 6 号 C 栋 3 楼）公司 C310 会议室以通讯表决方式召开。会议应参与表决董 事 9 人，实际参与表决董事 9 人。会议由董事长任桐主持，公司高级管理人员及 相关中介机构人员列席了会议。本次会议的召集、召开和表决程序符合有关法律、 法规和《公司章程》的规定，会议形成的决议合法有效。 二、董事会会议审议情况 本次会议以记名方式投票表决，审议通过以下事项： 1.审议通过《关于聘任公司高级管理人员的议案》 为了进一步加强公司经营管理，经公司副董事长兼总经理张烨镝先生提名, 董事会同意聘任张晨先 ...

（文章来源：每日经济新闻） 每经AI快讯，影视院线板块短线走低，博纳影业跌停，中国电影、欢瑞世纪、奥飞娱乐、幸福蓝海、 万达电影等跟跌。 ...

Group 1 - The film industry sector opened weakly on December 19, with Bona Film Group falling over 7% [1] - Other companies such as China Film, Beijing Culture, Huace Film & TV, and Happiness Blue Sea also experienced declines [1]

Group 1 - The film stocks that rebounded yesterday returned to weakness today, with a collective drop at the beginning of the trading session [1] - Bona Film Group fell over 7%, China Film Group dropped over 5%, and Beijing Culture decreased nearly 4% [1] - Other companies such as Huace Film & Television, Huayi Brothers, and Happiness Blue Sea also saw declines of over 2% [1] Group 2 - Bona Film Group's market value is 13.7 billion, with a year-to-date increase of 63.13% [2] - China Film Group has a market value of 29.6 billion, with a year-to-date increase of 37.01% [2] - Beijing Culture's market value is 3.673 billion, with a year-to-date decrease of 25.97% [2] - Huace Film & Television has a market value of 15 billion, with a year-to-date increase of 10.14% [2] - Huayi Brothers has a market value of 5.632 billion, with a year-to-date decrease of 22.52% [2] - Happiness Blue Sea has a market value of 7.057 billion, with a year-to-date increase of 117.70% [2]